Catalyst Wire Dossier Catalyst Wire Dossier

Ricovir

· Mylan (Taiwan) Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ricovir, covering 2022-05-02 to 2022-05-02. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Ricovir® in Maintaining Durability of Viral Response in Chronic Hepatitis B Patients Who Have Been Treated With Viread® and Have Undetectable HBV DNA in Serum [Phase 4]

See pricing